ACCELERATED MEDICAL DIAGNOSTICS, INC

Company Information
Address 2121 SECOND ST B-101
DAVIS, CA, 95616-6567


Information

DUNS: 826929015

# of Employees: 0


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Feasibility of predicting AML response to induction chemotherapy

    Amount: $299,999.00

    Abstract There is a critical unmet medical need for a rapid accurate test to identify AML patients who are likely to respond to chemotherapy Presently induction chemotherapy with the DNA ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. OTHER FUNCTIONS PHASE 0 CARBOPLATIN MICRODOSING DIAGNOSTIC TRIAL.

    Amount: $1,499,894.00

    We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in lung and bladder cancer patients before they receive carboplatin therapy. Plati ...

    SBIRPhase II2012Department of Health and Human Services
  3. OTHER FUNCTIONS- RandD BIOMEDICAL (BASIC RESEARCH)

    Amount: $199,969.00

    A. Background Information We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in breast cancer patients before they receive oxalipla ...

    SBIRPhase I2012Department of Health and Human Services
  4. Phase 0 carboplatin microdosing diagnostics trial

    Amount: $195,550.00

    We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in cancer patients before they receive carboplatin or cisplatin therapy. PlatinDx ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government